Anurag Singh

MD
Radiation Oncology
2023 Buffalo Spree Top Doctors Badge

Dr. Singh is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2023

Cancers Treated:

Adrenal Chronic Lymphocytic Leukemia Head Neck Kidney Lung Lymphoma Mediastinal Melanoma Skin Thyroid Parathyroid

Research Interests:

SBRT (Stereotactic Body Radiation Therapy) Novel agents to improve radiation therapy Novel agents to protect against side effects of radiation therapy Development and implementation of imaging to improve radiation targeting Methods to improve quality of life following radiation therapy Impact of nutrition on patient outcomes

About Anurag Singh

Positions

Roswell Park Comprehensive Cancer Center
  • Professor of Oncology, Department of Radiation Medicine
  • Director, Radiation Research, Department of Radiation Medicine
  • Director, Head & Neck and Lymphoma Radiation Services
  • Co-Leader, Cancer Stress Biology Program
  • Associate Dean of Graduate Medical Education, Radiation Medicine

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

  • Professor of Medicine

Background

Education and Training:

  • MD - Washington University School of Medicine, St. Louis, MO
  • BS - Yale University

Residency:

  • Mallinckrodt Institute of Radiology, St. Louis, MO

Board Certification:

  • Radiation Oncology, American Board of Radiology

Professional Experience:

  • 09/2012-Present - Professor of Medicine, University at Buffalo
  • 07/2012-Present - Professor of Oncology, Director of Radiation Research, Roswell Park Cancer Institute
  • 07/2007–07/2012 - Associate Professor, Director of Radiation Medicine Residency Program, Director of Radiation Research, Roswell Park Cancer Institute, University at Buffalo
  • 07/2004-06/2007 - Attending Physician, Head of Molecular Imaging Section, Radiation Oncology Branch, National Cancer Institute

Honors & Awards:

  • 2013-2023 - Buffalo Spree Top Doctors
  • 2013-2020 - Top Doctors in Western New York (Castle Connolly)
  • 2021 - Walter T. Murphy Educator of the Year Award
  • 2020 - Educator of the Year (2019-2020), Association of Residents In Radiation Oncology (ARRO)
  • 2017 - ASTRO Basic/Translational Science Abstract Award, Sr. Investigator in the Clinical category for, “A Pilot Study of Stereotactic Body Radiation Therapy Combined With Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.”
  • 2016 - Walter T. Murphy Educator of the Year Award given by the Radiation Medicine residents for excellence in clinical education
  • 2016 - Commendation from ACGME Residency Progam Review: No citations & excellent compliance
  • 2015 - Commendation from ACGME Residency Progam Review: No citations & excellent compliance
  • 2011 Outstanding Accreditation Award from University at Buffalo, No citations and Commendable Practice ACGME Residency Program Review
  • 2010 - Educator of the Year (2009-2010), Association of Residents In Radiation Oncology (ARRO)
  • 2006 - CaPSure Mentor (for Nicole SImone)
  • 1995 - MENSA Research and Education Scholarship
  • 1995 - Magna Cum Laude Graduate, Yale University
  • 1994 - MENSA Research and Education Scholarship
  • 1994 - Xerox Technical Merit Scholarship

Research

Research Overview:

Dr. Singh's research seeks to improve patient survival and/or quality of life. Partnerships with basic scientists, epidemiologists, statisticians, physicians from other specialties, and hosts of additional experts develop novel, cutting edge care strategies which are then tested in clinical trials. Projects range from the ways radiation impacts the immune system immune system to new agents and approaches to limit the side effects of chemotherapy and radiation.

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Learn More
Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
Learn More
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
Learn More
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
Learn More
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
Learn More
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer
Learn More
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer
Learn More

Clinical Trials

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Learn More
Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
Learn More
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
Learn More
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
Learn More
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
Learn More
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer
Learn More
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer
Learn More
Can a commonly prescribed blood pressure drug improve survival for patients with esophageal cancer? Bonding through cancer treatment: Three friends bridge generations Financial counseling improves outcomes for head-and-neck cancer patients Cancer Innovations: Prioritizing quality of life while treating cancer Head and Neck Cancer Patients: New Relief for Chronic Dry Mouth Stereotactic Body Radiotherapy (SBRT)

Featured on Cancer Talk

Can a commonly prescribed blood pressure drug improve survival for patients with esophageal cancer?
Bonding through cancer treatment: Three friends bridge generations
Financial counseling improves outcomes for head-and-neck cancer patients

Showing all3 of 6

Publications

Full Publications list on PubMed

Representative Publications:

1. Chow J, Khan A, Gaudieri M, Wasik BJ, Conway A, Soh KT, Repasky EA, Schwaab T, Wallace PK, Abrams SI, Singh AK, Muhitch JB. Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006392. PubMed PMID: 37080610.

2. *Ma SJ, *Gill J, *Waldman O, *Yendamuri K, *Dunne-Jaffe C, *Chatterjee U, *Fekrmandi F, *Shekher R, *Iovoli A, Yao S, Oladeru OT, Singh AK. Association of Neighborhood-Level Household Income With 21-Gene Recurrence Score and Survival Among Patients With Estrogen Receptor-Positive Breast Cancer. JAMA Netw Open. 2023 Feb 1;6(2):e230179. doi: 10.1001/jamanetworkopen.2023.0179. PubMed PMID: 36809469; PubMed Central PMCID: PMC9945075.

3. *Ma SJ, Yu H, *Yu B, *Waldman O, *Khan M, *Chatterjee U, *Santhosh S, *Gill J, *Iovoli AJ, *Farrugia M, Shevorykin A, Carl E, Wooten K, Gupta V, McSpadden R, Kuriakose MA, Markiewicz MR, Al-Afif A, Hicks WL Jr, Platek ME, Seshadri M, Sheffer C, Warren GW, Singh AK. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer. JAMA Netw Open. 2022 Dec 1;5(12):e2245818. doi: 10.1001/jamanetworkopen.2022.45818. PubMed PMID: 36480200.

4. *Ma SJ, Wang K, *Iovoli AJ, Attwood K, Hermann GM, *Farrugia MK, Singh AK. Association of gabapentin with pain control and feeding tube placement among patients with head and neck cancer receiving chemoradiotherapy. JAMA Netw Open. 2022;5(5):e2212900. doi:10.1001/jamanetworkopen.2022.12900. PubMed PMID: 35583872.

5. Chen M, Qiao G, Hylander BL, Mohammadpour H, Wang XY, Subjeck JR, Singh AK, Repasky EA. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun. 2020 Apr 14;11(1):1821. doi: 10.1038/s41467-020-15676-0. PubMed PMID: 32286326.